https://pharmadog.xyz/news/356271 pharmadog en 2026-09-02T18:48:44.000Z Novartis CAR-T deaths raise questions over acceptable autoimmune risk https://pharmadog.xyz/news/356059 pharmadog en 2026-09-02T16:32:00.000Z Novartis and Bristol Myers pause autoimmune CAR-T trials after serious safety events https://pharmadog.xyz/news/355827 pharmadog en 2026-09-02T16:02:32.000Z FDA CBER director overrides review team to grant accelerated approval for Replimune's melanoma therapy Tudriqev https://pharmadog.xyz/news/355931 pharmadog en 2026-09-02T15:22:00.000Z UniQure files FDA priority review request for Huntington’s gene therapy AMT-130 https://pharmadog.xyz/news/355700 pharmadog en 2026-09-02T15:07:53.000Z UK regulator suspends Tavneos sales as MHRA follows EMA decision; UniQure files for Huntington's gene therapy approval https://pharmadog.xyz/news/355611 pharmadog en 2026-09-02T14:58:42.000Z Teva's experimental antibody cuts intestinal damage in celiac patients after gluten challenge https://pharmadog.xyz/news/134233 pharmadog en 2026-09-02T14:47:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/355547 pharmadog en 2026-09-02T14:12:00.000Z Teva reports positive mid-stage results for celiac disease antibody, BioMarin settles patent fight with Ascendis https://pharmadog.xyz/news/355636 pharmadog en 2026-09-02T14:06:12.000Z Funding announcements can hint at upcoming biotech hiring opportunities https://pharmadog.xyz/news/355443 pharmadog en 2026-09-02T14:00:43.000Z Deaths of two Chinese children receiving CRISPR therapy spark safety debate https://pharmadog.xyz/news/355507 pharmadog en 2026-09-02T14:00:00.000Z Medical groups issue new flu, Covid and RSV vaccination guidance for upcoming winter season https://pharmadog.xyz/news/356246 pharmadog en 2026-09-02T13:45:00.000Z Novartis telegraphs 130 job cuts amid biologics rethink in Switzerland https://pharmadog.xyz/news/355508 pharmadog en 2026-09-02T13:37:50.000Z ARPA-H grants funding to biotech firms developing custom RNA therapies amid broader biotech updates https://pharmadog.xyz/news/355509 pharmadog en 2026-09-02T13:29:52.000Z Former ARPA-H director launches startup to solve AI's basic challenges in health care https://pharmadog.xyz/news/355510 pharmadog en 2026-09-02T13:26:55.000Z UniQure submits experimental Huntington's gene therapy to FDA for accelerated review https://pharmadog.xyz/news/355487 pharmadog en 2026-09-02T13:19:04.000Z UniQure submits FDA and UK applications for first Huntington’s disease gene therapy https://pharmadog.xyz/news/355359 pharmadog en 2026-09-02T12:06:07.000Z Beyond GLP-1s: Companies eye new obesity drug mechanisms as efficacy plateaus https://pharmadog.xyz/news/355231 pharmadog en 2026-09-02T11:59:16.000Z ADA internal review refutes censorship and police involvement allegations after conference ejections https://pharmadog.xyz/news/355211 pharmadog en 2026-09-02T11:38:48.000Z UK regulator suspends new patients from receiving Tavneos (Avacopan Vifor) amid data concerns https://pharmadog.xyz/news/355074 pharmadog en 2026-09-02T11:24:14.000Z Novartis’ BTK inhibitor remibrutinib cuts MS relapse rates in Phase 3, setting up FDA filing https://pharmadog.xyz/news/354951 pharmadog en 2026-09-02T11:00:57.000Z Typewriter secures $56M to advance jumping-gene platform and in vivo CAR-T therapies https://pharmadog.xyz/news/355586 pharmadog en 2026-09-02T10:29:00.000Z Teva's anti-IL-15 antibody meets primary endpoint in phase 2a celiac disease trial https://pharmadog.xyz/news/355588 pharmadog en 2026-09-02T10:17:00.000Z SEC and FDA sign three-year info-sharing pact to boost market integrity and public-health oversight https://pharmadog.xyz/news/355587 pharmadog en 2026-09-02T10:14:00.000Z TScan Therapeutics cuts 75% of staff to focus on preclinical solid tumor programs https://pharmadog.xyz/news/354827 pharmadog en 2026-09-02T09:52:38.000Z Novartis and BMS pause CAR‑T trials after patient deaths while Revolution Medicines gains early FDA approval for pancreatic cancer drug https://pharmadog.xyz/news/354719 pharmadog en 2026-09-02T08:30:00.000Z Trump’s new pharma deals lower Medicaid prices but shield Medicare from cuts https://pharmadog.xyz/news/354720 pharmadog en 2026-09-02T08:30:00.000Z Ig Nobel Prizes move to Zurich as organizers cite US immigration concerns https://pharmadog.xyz/news/354721 pharmadog en 2026-09-02T08:30:00.000Z Experts urge next DSM to consider algorithmic influence on eating disorders https://pharmadog.xyz/news/355310 pharmadog en 2026-09-02T07:51:00.000Z Novartis signs up to $3.2 billion deal with Korea's Alteogen for subcutaneous drug delivery technology https://pharmadog.xyz/news/354039 pharmadog en 2026-09-02T04:39:00.000Z Biotech reverse mergers surge 1,600% in Q3, matching number of IPOs in 2026 https://pharmadog.xyz/news/354040 pharmadog en 2026-09-02T04:18:00.000Z BMS faces steep risk if milvexian trial fails, could spark mega-cap merger frenzy https://pharmadog.xyz/news/356187 pharmadog en 2026-09-02T04:00:00.000Z Early Alert: Convenience Kit Issue from AVID Medical https://pharmadog.xyz/news/353015 pharmadog en 2026-09-01T23:06:00.000Z ADA internal review rejects claims of silencing protest after member expulsions https://pharmadog.xyz/news/353016 pharmadog en 2026-09-01T23:00:00.000Z ADA reviews June conference disruptions, finds no censorship of editorial https://pharmadog.xyz/news/352419 pharmadog en 2026-09-01T19:26:54.000Z Google Gemini adds Zocdoc booking, while Solv partners with Amazon https://pharmadog.xyz/news/352194 pharmadog en 2026-09-01T18:32:08.000Z ARPA-H grants up to $125M to accelerate on-demand custom RNA therapy manufacturing https://pharmadog.xyz/news/352195 pharmadog en 2026-09-01T18:16:50.000Z Trump announces voluntary pricing agreements with nine new drug makers https://pharmadog.xyz/news/352099 pharmadog en 2026-09-01T18:09:57.000Z House passes stopgap bill to block White House plan for political control of federal research grants https://pharmadog.xyz/news/354374 pharmadog en 2026-09-01T17:35:00.000Z Absci CEO envisions AI-driven, consumer-focused drug platform, eyeing hair loss, endometriosis and future GLP-1 combos https://pharmadog.xyz/news/352100 pharmadog en 2026-09-01T17:28:37.000Z Trial over Lindsay Clancy’s case threatens progress in postpartum psychiatry https://pharmadog.xyz/news/352035 pharmadog en 2026-09-01T17:12:58.000Z Arsenal Biosciences trims most of its workforce as it shifts focus to in vivo CAR T therapy https://pharmadog.xyz/news/351863 pharmadog en 2026-09-01T16:14:00.000Z Mid-size biotechs join White House Medicaid pricing program, gain tariff relief https://pharmadog.xyz/news/351864 pharmadog en 2026-09-01T15:58:00.000Z Novartis reports Phase 3 success for MS pill remibrutinib, beats Aubagio and shows no liver safety issues https://pharmadog.xyz/news/351803 pharmadog en 2026-09-01T15:28:05.000Z Roche partners with China's Simcere Zaiming on $1.5 billion T-cell engager for B-cell diseases https://pharmadog.xyz/news/351865 pharmadog en 2026-09-01T15:28:00.000Z Alumis' TYK2 inhibitor flunks mid-stage lupus trial, shares drop 55% https://pharmadog.xyz/news/351583 pharmadog en 2026-09-01T15:01:06.000Z Eli Lilly's 2026 acquisitions boost over 50 biotech venture investors https://pharmadog.xyz/news/351823 pharmadog en 2026-09-01T14:51:22.000Z Trump administration announces new drug pricing pledges, but details remain undisclosed https://pharmadog.xyz/news/351584 pharmadog en 2026-09-01T14:40:34.000Z GSK to begin Phase 3 trial of mRNA seasonal flu vaccine after strong Phase 2 results https://pharmadog.xyz/news/351585 pharmadog en 2026-09-01T14:40:27.000Z Roche partners with Simcere Zaiming on trispecific T cell engager, $75M upfront https://pharmadog.xyz/news/351586 pharmadog en 2026-09-01T14:24:39.000Z Alumis' TYK2 lupus drug fails mid-stage trial, CEO says clear path forward https://pharmadog.xyz/news/351656 pharmadog en 2026-09-01T14:09:09.000Z GSK to start Phase 3 trial of mRNA flu vaccine after strong mid-stage results https://pharmadog.xyz/news/351479 pharmadog en 2026-09-01T13:34:13.000Z Novartis reports positive multiple sclerosis results with its BTK inhibitor https://pharmadog.xyz/news/351480 pharmadog en 2026-09-01T13:21:06.000Z Novartis and Bristol Myers Squibb pause cell therapy trials; $480K cancer drug price now routine, new pricing deals announced https://pharmadog.xyz/news/351351 pharmadog en 2026-09-01T13:10:20.000Z FDA clears Stryker’s surgical cockpit that integrates Apple Vision Pro VR headset https://pharmadog.xyz/news/351352 pharmadog en 2026-09-01T13:08:31.000Z Study finds Paxlovid ineffective for treating long Covid https://pharmadog.xyz/news/351307 pharmadog en 2026-09-01T13:00:43.000Z K Health plans IPO by 2029 after recent funding round https://pharmadog.xyz/news/351331 pharmadog en 2026-09-01T12:20:57.000Z Arsenal Biosciences cuts 99 jobs as it pivots to in vivo CAR-T therapy https://pharmadog.xyz/news/351203 pharmadog en 2026-09-01T12:03:04.000Z House set to vote on stopgap bill that could block White House plan to politicize NIH grants https://pharmadog.xyz/news/351183 pharmadog en 2026-09-01T12:02:14.000Z Nine midsize biopharma firms join Trump MFN drug pricing program, covering 89% of branded market https://pharmadog.xyz/news/351184 pharmadog en 2026-09-01T11:54:53.000Z Novartis and BMS pause CAR-T trials after fatal immune syndrome cases https://pharmadog.xyz/news/351139 pharmadog en 2026-09-01T11:30:44.000Z Novartis' Rhapsido shows safety edge and relapse reduction in Phase 3 multiple sclerosis trials https://pharmadog.xyz/news/351558 pharmadog en 2026-09-01T10:01:00.000Z Roche signs $1.53 billion licensing deal with Simcere for preclinical B-cell antibody https://pharmadog.xyz/news/351559 pharmadog en 2026-09-01T09:51:00.000Z Arsenal Biosciences cuts 99 jobs as it pivots to in-vivo CAR-T therapy https://pharmadog.xyz/news/351391 pharmadog en 2026-09-01T09:28:00.000Z Alumis' lupus trial misses endpoints, but company eyes phase 3 in IFNGS‑high subgroup https://pharmadog.xyz/news/351392 pharmadog en 2026-09-01T09:02:00.000Z Novocure cyberattack exposes data of over 1,400 U.S. patients and staff https://pharmadog.xyz/news/350691 pharmadog en 2026-09-01T08:30:00.000Z NIH proposes cap on individual research grants, drawing mixed reactions https://pharmadog.xyz/news/350693 pharmadog en 2026-09-01T08:30:00.000Z Dietitian Shortage Threatens Trump Administration's Nutrition Initiatives https://pharmadog.xyz/news/350692 pharmadog en 2026-09-01T08:30:00.000Z Opinion: Trump administration’s paperwork surge hampers science and health care https://pharmadog.xyz/news/350730 pharmadog en 2026-09-01T05:43:00.000Z GSK's mRNA flu vaccine shows stronger immune response than standard shots in phase 2, prompting phase 3 launch https://pharmadog.xyz/news/351499 pharmadog en 2026-09-01T04:00:00.000Z Medline recalls neonatal and infant heated wire breathing circuits over connector failures https://pharmadog.xyz/news/351390 pharmadog en 2026-09-01T03:18:00.000Z Medtronic recalls Bravo CF reflux monitoring capsule after 184 serious injuries reported https://pharmadog.xyz/news/351282 pharmadog en 2026-09-01T02:47:00.000Z Boston Scientific stops sales of Imager II catheters after tip defect linked to two injuries https://pharmadog.xyz/news/349435 pharmadog en 2026-09-01T00:55:30.000Z ARCH Venture Partners aims to raise $3 billion for its 14th biotech fund https://pharmadog.xyz/news/349159 pharmadog en 2026-09-01T00:01:19.000Z Novartis halts CD19 CAR-T trial after three deaths, Bristol Myers also pauses similar program https://pharmadog.xyz/news/353983 pharmadog en 2026-09-01T00:00:00.000Z Trump unveils pricing agreements with midsize biotech firms; Novartis halts CAR-T trial after patient deaths https://pharmadog.xyz/news/353982 pharmadog en 2026-09-01T00:00:00.000Z FDA releases draft guidance on evaluating drug behavior in patients with liver impairment https://pharmadog.xyz/news/353981 pharmadog en 2026-09-01T00:00:00.000Z FDA urges validation of digital health endpoints and clear missing-data plans https://pharmadog.xyz/news/348987 pharmadog en 2026-08-31T21:38:00.000Z Novartis and Bristol Myers pause autoimmune CAR-T trials after safety concerns https://pharmadog.xyz/news/348563 pharmadog en 2026-08-31T20:00:00.000Z New American Headache Society guidelines highlight expanded migraine prevention options https://pharmadog.xyz/news/348499 pharmadog en 2026-08-31T19:56:17.000Z Trump announces nine voluntary drug pricing agreements with mid-size biotech firms https://pharmadog.xyz/news/348564 pharmadog en 2026-08-31T19:48:44.000Z Trump announces nine new drug pricing agreements to align U.S. prices with peer nations